FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns an influenza vaccine and method for preparing it. Substance of the invention involves the influenza vaccine containing the coupling of purified influenza virus antigens and a polymeric carrier representing 2-methyl-5-vinylpyridine and N-vinylpyrrolidone copolymer in proportions 1: 5-30, and a method for preparing the influenza vaccine involving the cultivation of influenza virus strain in chicken embryos to produce a purified viral concentrate that is followed by inactivating, splitting the viral concentrate to produce the purified influenza virus antigens and coupling with the polymer carrier representing 2-methyl-5-vinylpyridine and N-vinylpyrrolidone copolymer in proportions 1: 5-30.
EFFECT: preparation of the vaccine.
2 cl, 5 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING TETRAVALENT SUBUNIT INFLUENZA VACCINE | 2019 |
|
RU2740751C1 |
| PENTAVALENT SUBUNIT VACCINE AGAINST RESPIRATORY INFECTIONS AND METHOD OF ITS PREPARATION | 2022 |
|
RU2804948C2 |
| METHOD OF PRODUCING ANTIGEN OR ANTIGENS FOR PRODUCTION OF INFLUENZA VACCINE AND A VACCINE BASED ON IT | 2019 |
|
RU2710239C1 |
| METHOD FOR OBTAINING A TETRAVALENT VACCINE FOR THE PREVENTION OF INFLUENZA | 2020 |
|
RU2754398C1 |
| INACTIVATED SPLIT INFLUENZA VACCINE AND PREPARATION METHOD THEREOF | 2015 |
|
RU2584594C1 |
| STRAIN OF INFLUENZA VIRUS A/HK/HK/6:2/2016 (H9N2) FOR PRODUCING INACTIVATED AND LIVE INFLUENZA VACCINES | 2018 |
|
RU2702833C1 |
| STRAIN OF INFLUENZA VIRUS A/UNL/HK/2:6/2017 (H5N8) FOR PRODUCING INACTIVATED AND LIVE INFLUENZA VACCINES | 2018 |
|
RU2702834C1 |
| METHOD OF PREPARING INFLUENZA VACCINE | 2009 |
|
RU2423995C1 |
| INFLUENZA VACCINE | 2014 |
|
RU2546861C1 |
| METHOD FOR PREVENTING INFLUENZA BY COMBINED APPLICATION OF INTERFERON GAMMA AND INACTIVATED ANTI-INFLUENZA VACCINE | 2011 |
|
RU2546540C2 |
